Even as Amazon’s Kindle Fire and other tablets play catch-up in the consumer market, the iPad faces little competition among corporations such as financial services and pharmaceutical firms. Apple’s iPhone, meanwhile, is the top-selling smart phone, forcing businesses to accommodate workers who use it. That has helped set the stage for Apple’s Mac computer to make its own inroads in the corporate world.
“We haven’t seen a single pharma deploy on anything but the iPad,” said Matt Wallach, co-founder of Veeva Systems, a Pleasanton maker of sales software for drug companies. “I’ve seen a lot of devices come and go over the years. Nothing touches the speed of adoption of the iPad.”